How does an Intrauterine Device (IUD) deliver constant progesterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Constant Progesterone Delivery from Hormonal IUDs

The levonorgestrel IUD delivers constant progesterone (technically, the progestin levonorgestrel) through a silastic reservoir attached to the device's vertical arm, which is covered with a rate-limiting silastic membrane that releases approximately 20 micrograms of levonorgestrel per 24 hours directly into the uterine cavity for at least 5 years. 1

Physical Design and Release Mechanism

  • The device consists of a T-shaped frame with a silastic (silicone elastomer) reservoir impregnated with levonorgestrel attached to its vertical arm 1

  • A rate-limiting silastic membrane covers the reservoir, which controls the steady release of hormone into the uterine cavity 1

  • This membrane technology ensures a predictable, continuous daily release rate of approximately 20 micrograms of levonorgestrel over an extended period 2, 1

Local vs. Systemic Delivery

  • The intrauterine administration delivers hormone directly into the uterine cavity, where it causes pronounced endometrial suppression with minimal systemic absorption 1

  • The dose of hormone is so low that the effect on ovarian function is negligible in most women, though some disruption of follicular development can occur 3

  • This local delivery mechanism distinguishes hormonal IUDs from oral or transdermal progesterone, which have higher systemic hormone levels 4

Duration of Constant Release

  • The levonorgestrel reservoir maintains its release rate of approximately 20 micrograms per 24 hours for at least 5 years, which is the FDA-approved duration 5, 1

  • Clinical evidence demonstrates effectiveness extending to 7-8 years, with cumulative failure rates remaining below 1% during years 6-8 5

Important Clinical Caveat

  • Note that hormonal IUDs contain levonorgestrel (a progestin), not natural progesterone—this is a synthetic progestogen that mimics progesterone's effects 5, 6

  • The American College of Obstetricians and Gynecologists confirms levonorgestrel is the only hormone used in hormonal IUDs currently available in the United States 5

References

Research

The levonorgestrel intrauterine system: more than a contraceptive.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2001

Research

Hormonal intrauterine devices.

Annals of medicine, 1993

Guideline

Levonorgestrel Intrauterine Device (IUD) Contraception and Therapeutic Benefits

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.